Anti-MOG Antibodies in Japanese Patients with Neuromyelitis Optica Spectrum Disorders by Sato, D, Nakashima, I, Takahashi, T, Misu, T, Kuroda, H, Nishiyama, S, Waters, P, Fujihara, K

The Importance of Aquaporin-4 Antibody Assays in Patients beyond the Diagnostic Criteria for Neuromyelitis Optica Spectrum Disorders by Sato, D, Nakashima, I, Takahashi, T, Misu, T, Waters, P, Kuroda, H, Nishiyama, S, Suzuki, C, Takai, Y, Itoyama, Y, Fujihara, K, Aoki, M

Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders. by Sato, D, Nakashima, I, Takahashi, T, Misu, T, Waters, P, Kuroda, H, Nishiyama, S, Suzuki, C, Takai, Y, Fujihara, K, Itoyama, Y, Aoki, M

THE ASSOCIATION OF TWO RARE NEUROLOGICAL DISEASES: A MULTICENTRE STUDY OF 16 PATIENTS WITH ACHR ANTIBODY MYASTHENIA GRAVIS AND AQP4 ANTIBODY NEUROMYELITIS OPTICA SPECTRUM DISORDER by Leite, M, Coutinho, E, Callegaro, D, Lana-Peixoto, M, Waters, P, Sato, D, Melamud, L, Graham, A, Vincent, A, Palace, J

Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders. by Sato, D, Callegaro, D, Lana-Peixoto, M, Waters, P, de Haidar Jorge, F, Takahashi, T, Nakashima, I, Apostolos-Pereira, S, Talim, N, Simm, R, Lino, A, Misu, T, Leite, M, Aoki, M, Fujihara, K

MOG cell-based assay detects non-MS patients with inflammatory neurologic disease by Waters, P, Woodhall, M, O'Connor, K, Reindl, M, Lang, B, Sato, D, Juryńczyk, M, Tackley, G, Rocha, J, Takahashi, T, Misu, T, Nakashima, I, Palace, J, Fujihara, K, Leite, M, Vincent, A

Prevalence and clinical characteristics of neuromyelitis optica spectrum disorders patients with myelin oligodendrocyte glycoprotein antibodies by Sato, D, Jorge, F, Lana-Peixoto, M, Waters, P, Nakashima, I, Apostolos Pereira, S, Talim, N, Takahashi, T, Zago, P, Leite, M, Bosso, K, Simm, R, Misu, T, Aoki, M, Fujihara, K, Callegaro, D

Myelin injury without astrocytopathy in neuroinflammatory disorders with MOG antibodies. by Kaneko, K, Sato, D, Nakashima, I, Nishiyama, S, Tanaka, S, Marignier, R, Hyun, J, Oliveira, L, Reindl, M, Seifert-Held, T, Sepulveda, M, Siritho, S, Waters, P, Kurosawa, K, Akaishi, T, Kuroda, H, Misu, T, Prayoonwiwat, N, Berger, T, Saiz, A, Kim, H, Nomura, K, Callegaro, D, Fujihara, K, Aoki, M

Myasthenia gravis and neuromyelitis optica spectrum disorder: a multicenter study of 16 patients. by Leite, M, Coutinho, E, Lana-Peixoto, M, Apostolos, S, Waters, P, Sato, D, Melamud, L, Marta, M, Graham, A, Spillane, J, Villa, A, Callegaro, D, Santos, E, da Silva, A, Jarius, S, Howard, R, Nakashima, I, Giovannoni, G, Buckley, C, Hilton-Jones, D, Vincent, A, Palace, J

Disruption at the PTCHD1 Locus on Xp22.11 in Autism spectrum disorder and intellectual disability. by Noor, A, Whibley, A, Marshall, C, Gianakopoulos, P, Piton, A, Carson, A, Orlic-Milacic, M, Lionel, A, Sato, D, Pinto, D, Drmic, I, Noakes, C, Senman, L, Zhang, X, Mo, R, Gauthier, J, Crosbie, J, Pagnamenta, A, Munson, J, Estes, A, Fiebig, A, Franke, A, Schreiber, S, Stewart, A, Roberts, R